The INVANZ brand and generic market had U.S. sales of approximately US $205 million MAT for the most recent twelve months ending March 2021 according to IQVIA Health
Second quarter sales of $2.5 billion increased thirteen percent due to seven percent higher energy cost pass-through, four percent favorable currency
The Group will work to accelerate the creation and development of new businesses
MGC has been working on geothermal power generation, which generates less carbon dioxide (CO2) during power generation
Project to be conducted with University of Minnesota’s Forever Green Initiative to investigate pennycress oil in production of polyhydroxyalkanoate (PHA), a biodegradable plastic alternative
Closed $0.5 billion of asset sales, including non-core assets in the DJ Basin
Construction on the plant is expected to begin at the end of the year
The plasticizers, which are drop-in replacements for existing products, offer the identical performance of Eastman's legacy products but with 20%–59% recycled content
The Department of Pharma has allocated this drug amongst the states/UTs based on expected supply that will be available from May 10 to May 31, 2021
Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases
The company has managed to launch one product and got approvals for four more during the first four months
Lanxess lifts profit forecast floor as auto sector recovers
Net income advances by 40.3 percent to 2.089 billion euros
Syngenta and Valagro received access to certain limited confirmatory due diligence information
The tablets will be manufactured and marketed under Vivimed’s brand name “Favulous” across India
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
The ratings also factor in the healthy net worth and comfortable capital structure of the Group at a consolidated level
Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021
BASF India has posted net profit of Rs.552.61 crores for the 12 months period ended March 31, 2021
The company reported total income of Rs.1997.79 crores during the period ended March 31, 2020.
Subscribe To Our Newsletter & Stay Updated
